Sarah E Ashley

13PUBLICATIONS
23CO-AUTHORS
AllergyPacific Peoples diet and nutritionPacific Peoples mothers and babies health and wellbeingInnate immunityImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 21, 2026
Three-Year Post-Treatment Outcomes Following Cessation of Peanut Oral Immunotherapy: Comparisons by Clinical Allergy Status and Treatment Group.

|May 25, 2026
Correlation and Agreement Between Parent-Report and Self-Report Food Allergy Quality of Life Questionnaires After Oral Immunotherapy.

|Oct 16, 2025
Probiotic oral immunotherapy for egg and milk allergy induces sustained unresponsiveness.

Melanie Lloyd, Paxton Loke, Kathy Nguyen

|Aug 22, 2025
Sex assigned at birth may modify health-related quality of life in children treated with peanut oral immunotherapy.

Sophie A Rosser, Melanie Lloyd, Paxton Loke

|Jul 22, 2025
Understanding the Variability of Peanut-Oral Immunotherapy Responses by Multi-Omics Profiling of Immune Cells.

Aleix Arnau-Soler, Sarah E Ashley, Ahla Ghauri

|Dec 26, 2024
Allergen-Specific IgE is a Stronger Predictor of Remission Following Peanut Oral Immunotherapy Than Age in Children Aged 1-10 Years.

Sarah E Ashley, Melanie Lloyd, Paxton Loke

Pageof 3

Frequent Collaborators

7 joint publications

Paxton Loke

3 joint publications

Sophie Rosser

2 joint publications

Kuang-Chih Hsiao

2 joint publications

Melanie Lloyd